121
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Inhibition of pro-inflammatory cytokines and inducible nitric oxide by extract of Emilia sonchifolia L. aerial parts

, , &
Pages 925-931 | Received 10 Apr 2012, Accepted 19 May 2012, Published online: 20 Jun 2012

References

  • Spelman, K., Burns, J., Nichols, D., Winters, N., Ottersberg, S., Tenborg, M. Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern Med Rev 2006, 11, 128–150.
  • Iwu MM. Igbo traditional medicine. Nsukka: Institute of African Studies, University of Nigeria 1986; p. 30–35.
  • Nadkarni KM, Nadkarni AK. Indian Materia Medica. Bombay: Popular Prakashanm, 1976.
  • Shylesh, B.S., Padikkala, J. In vitro cytotoxic and antitumor property of Emilia sonchifolia (L.) DC in mice. J Ethnopharmacol 2000, 73, 495–500.
  • Warrier P.K., Nambiar V.P.K., Ramankutty C. In: Vaidyarathnam P.S., editor. Indian medicinal plants, a compendium of 500 species, vol. 2. Madras: Varier’s Orient Longman Ltd, 1994; p. 372–373.
  • Cheng, D., Röder, E. [Pyrrolizidine Alkaloids from Emilia sonchifolia.]. Planta Med 1986, 6, 484–486.
  • Srinivasan K.K., Subramanian S.S.. Phytochemical screening of Emilia sonchifolia. Fitoterapia 1980; 51: 241–242.
  • Couto, V.M., Vilela, F.C., Dias, D.F., Dos Santos, M.H., Soncini, R., Nascimento, C.G., Giusti-Paiva, A. Antinociceptive effect of extract of Emilia sonchifolia in mice. J Ethnopharmacol 2011, 134, 348–353.
  • Muko, K.N., Ohiri, F.C. A preliminary study on the anti-inflammatory properties of Emilia sonchifolia leaf extracts. Fitoterapia 2000, 71, 65–68.
  • Shylesh B.S., Padikkala J. Antioxidant and anti-inflammatory activity of Emilia sonchifolia. Fitoterapia 1999; 70, 275–278.
  • Tripathi, S., Bruch, D., Kittur, D.S. Ginger extract inhibits LPS induced macrophage activation and function. BMC Complement Altern Med 2008, 8, 1.
  • Kim, S.J., Jeong, H.J., Moon, P.D., Lee, K.M., Lee, H.B., Jung, H.J., Jung, S.K., Rhee, H.K., Yang, D.C., Hong, S.H., Kim, H.M. Anti-inflammatory activity of gumiganghwaltang through the inhibition of nuclear factor-κ B activation in peritoneal macrophages. Biol Pharm Bull 2005, 28, 233–237.
  • Evans W.C. Trease and Evans pharmacognosy 14th edition. London: WB Saunders Company Limited 1998; p. 15–16.
  • Harborne J.B., Harborne A.J. (Eds.) 1998. Phytochemical methods: a guide to modern techniques of plant analysis. London: Kluwer Academic Publishers.
  • Lin, H., Chen, C., Chen, B.D. Resistance of bone marrow-derived macrophages to apoptosis is associated with the expression of X-linked inhibitor of apoptosis protein in primary cultures of bone marrow cells. Biochem J 2001, 353, 299–306.
  • Weischenfeldt J., Porse B. Bone marrow-derived macrophages (BMM): Isolation and applications. Cold Spring Harbor Protocols; 2008. Available at: http://cshprotocols.cshlp.org/cgi/content/full/2008/13/pdb.prot5080.
  • Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65, 55–63.
  • Krakauer, T. Molecular therapeutic targets in inflammation: cyclooxygenase and NF-κB. Curr Drug Targets Inflamm Allergy 2004, 3, 317–324.
  • Esposito, K., Giugliano, D. The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis 2004, 14, 228–232.
  • Ohshima, H., Bartsch, H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994, 305, 253–264.
  • Hong Y.H., Chao W.W., Chen M.L., Lin B.F. Ethyl acetate extracts of alfalfa (Medicago sativa L.) sprouts inhibit lipopolysaccharide-induced inflammation in vitro and in vivo. J Biomed Sci 2009; 16:64.
  • Pearson, W., Fletcher, R.S., Kott, L.S., Hurtig, M.B. Protection against LPS-induced cartilage inflammation and degradation provided by a biological extract of Mentha spicata. BMC Complement Altern Med 2010, 10, 19.
  • Raza, A. Anti-TNF therapies in rheumatoid arthritis, Crohn’s disease, sepsis, and myelodysplastic syndromes. Microsc Res Tech 2000, 50, 229–235.
  • Wheeler, A.P., Bernard, G.R. Treating patients with severe sepsis. N Engl J Med 1999, 340, 207–214.
  • Turini, M.E., DuBois, R.N. Cyclooxygenase-2: a therapeutic target. Annu Rev Med 2002, 53, 35–57.
  • Korhonen, R., Lahti, A., Kankaanranta, H., Moilanen, E. Nitric oxide production and signaling in inflammation. Curr Drug Targets Inflamm Allergy 2005, 4, 471–479.
  • Duval, D.L., Miller, D.R., Collier, J., Billings, R.E. Characterization of hepatic nitric oxide synthase: identification as the cytokine-inducible form primarily regulated by oxidants. Mol Pharmacol 1996, 50, 277–284.
  • Adams, L.B., Hibbs, J.B. Jr, Taintor, R.R., Krahenbuhl, J.L. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol 1990, 144, 2725–2729.
  • Stuehr, D.J., Nathan, C.F. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989, 169, 1543–1555.
  • Suk, K., Somers, S.D., Erickson, K.L. Regulation of murine macrophage function by IL-4: IL-4 and IFN-γ differentially regulate macrophage tumoricidal activation. Immunology 1993, 80, 617–624.
  • Guzik, T.J., Korbut, R., Adamek-Guzik, T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 2003, 54, 469–487.
  • Moncada, S., Palmer, R.M., Higgs, E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43, 109–142.
  • Snyder, S.H., Bredt, D.S. Biological roles of nitric oxide. Sci Am 1992, 266, 68–71, 74.
  • Liu, S.F., Ye, X., Malik, A.B. Inhibition of NF-κB activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes. Circulation 1999, 100, 1330–1337.
  • Ziegler-Heitbrock, H.W., Sternsdorf, T., Liese, J., Belohradsky, B., Weber, C., Wedel, A., Schreck, R., Bäuerle, P., Ströbel, M. Pyrrolidine dithiocarbamate inhibits NF-κ B mobilization and TNF production in human monocytes. J Immunol 1993, 151, 6986–6993.
  • Hajri, A., Metzger, E., Vallat, F., Coffy, S., Flatter, E., Evrard, S., Marescaux, J., Aprahamian, M. Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies. Br J Cancer 1998, 78, 841–849.
  • Nascimento, F.R., Ribeiro-Dias, F., Russo, M. Cytotoxic activity of BCG-activated macrophages against L929 tumor cells is nitric oxide-dependent. Braz J Med Biol Res 1998, 31, 1593–1596.
  • Akira, S., Uematsu, S., Takeuchi, O. Pathogen recognition and innate immunity. Cell 2006, 124, 783–801.
  • Beutler, B., Jiang, Z., Georgel, P., Crozat, K., Croker, B., Rutschmann, S., Du, X., Hoebe, K. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol 2006, 24, 353–389.
  • Creagh, E.M., O’Neill, L.A. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 2006, 27, 352–357.
  • Beutler, B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004, 430, 257–263.
  • Yamamoto, M., Akira, S. [TIR domain–containing adaptors regulate TLR-mediated signaling pathways]. Nippon Rinsho 2004, 62, 2197–2203.
  • Iwalewa E.O., McGaw L.J., Naidoo V., Eloff J.N. Inflammation: the foundation of diseases and disorders. A review of phytomedicines of South African origin used to treat pain and inflammatory conditions. Afr J Biotech. 2007; 6: 2868–2885.
  • Soliman, K.F., Mazzio, E.A. In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds. Proc Soc Exp Biol Med 1998, 218, 390–397.
  • Wagner H. (1990). Search for plant derived natural products with immunostimulatory activity (recent advances). Pure Appl Chem, 62: 1217–1222.
  • Lija, Y., Biju, P.G., Reeni, A., Cibin, T.R., Sahasranamam, V., Abraham, A. Modulation of selenite cataract by the flavonoid fraction of Emilia sonchifolia in experimental animal models. Phytother Res 2006, 20, 1091–1095.
  • Ferriola, P.C., Cody, V., Middleton, E. Jr. Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol 1989, 38, 1617–1624.
  • Kim, H.P., Son, K.H., Chang, H.W., Kang, S.S. Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci 2004, 96, 229–245.
  • Xagorari, A., Roussos, C., Papapetropoulos, A. Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin. Br J Pharmacol 2002, 136, 1058–1064.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.